ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Cash from investing

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2025-2,422+3.59%
Dec 31, 2024-2,338-25.38%
Dec 31, 2023-3,133+80.06%
Dec 31, 2022-1,740-13.35%
Dec 31, 2021-2,008-9.35%
Dec 31, 2020-2,215+22.04%
Dec 31, 2019-1,815+33.85%
Dec 31, 2018-1,356-85.90%
Dec 31, 2017-9,618+3778.23%
Dec 31, 2016-248-161.08%
Dec 31, 2015406-110.33%
Dec 31, 2013-3,929-1606.33%
Dec 31, 2011261-102.14%
Dec 31, 2010-12,188

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat